- $283.3 million of series 2012A bonds
- $75 million of series 2009B bonds
- $66.8 million of series 2009C bonds
The rating downgrade is based on a number of factors, including WakeMed’s negative operating margin in fiscal year 2015 and its location in a competitive service area.
The outlook has been revised to stable from negative.
More articles on healthcare finance:
5 latest hospital bankruptcies, closures
NYC budget includes $700M boost for public hospitals
Bipartisan health spending bill passes appropriations committee
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
